TOKYO – Alexion Pharmaceuticals Inc. is looking for Japanese approval for its drug, asfotase alfa, to treat patients suffering from hypophosphatasia (HPP), an ultra-rare genetic bone disorder.

TOKYO – Alexion Pharmaceuticals Inc. is looking for Japanese approval for its drug, asfotase alfa, to treat patients suffering from hypophosphatasia (HPP), an ultra-rare genetic bone disorder.

TOKYO – For three decades now, a dengue pandemic has move around the world, making its way to Europe, the U.S., China and, since last month, Japan. For the first time in 70 years, a local case of dengue was identified in Tokyo. Neglected diseases like malaria, Chagas and dengue, are coming back into the spotlight in Japan thanks to the dengue outbreak and now an infusion of research capital.

TOKYO – For three decades now, a dengue pandemic has moved around the world, making its way to Europe, the U.S., China and, since last month, Japan. For the first time in 70 years, a local case of dengue was identified in Tokyo. Neglected diseases like malaria, Chagas and dengue are coming back into the spotlight in Japan thanks to the dengue outbreak and now an infusion of research capital.

TOKYO – The government of Prime Minister Shinzo Abe plans to bring together government institutions, private companies and academia to assist with the commercialization of Japan's first-class drugs and medical devices.

TOKYO – The Japanese arm of Swiss pharma giant Novartis AG admitted to government regulators it failed to report more than 2,500 cases of serious side effects in patients who had received its leukemia and cancer drugs.

TOKYO – The government of Prime Minister Shinzo Abe plans to bring together government institutions, private companies and academia to assist with the commercialization of Japan's first-class drugs and medical devices.

TOKYO – One more Japanese company has taken a step closer to the biosimilars market through a strategic drug development alliance with a U.S. company and a drug for rheumatoid arthritis.